$127 Million is the total value of Michael & Susan Dell Foundation's 7 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CCI | CROWN CASTLE INTL CORP NEW | $54,408,000 | -0.2% | 544,185 | 0.0% | 42.89% | -0.5% | |
JPM | JPMORGAN CHASE & CO | $29,976,000 | +4.5% | 313,853 | 0.0% | 23.63% | +4.2% | |
AET | AETNA INC NEW | $19,815,000 | +4.7% | 124,616 | 0.0% | 15.62% | +4.4% | |
XON | INTREXON CORP | $8,229,000 | -21.1% | 432,878 | 0.0% | 6.49% | -21.3% | |
BRKB | BERKSHIRE HATHAWAY INC DELcl b new | $7,241,000 | +8.2% | 39,500 | 0.0% | 5.71% | +7.9% | |
WMB | WILLIAMS COS INC DEL | $6,763,000 | -0.9% | 225,363 | 0.0% | 5.33% | -1.2% | |
ZIOP | ZIOPHARM ONCOLOGY INC | $410,000 | -1.2% | 66,749 | 0.0% | 0.32% | -1.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
JPMORGAN CHASE & CO | 23 | Q3 2019 | 57.9% |
AETNA INC NEW | 20 | Q3 2018 | 28.3% |
INTREXON CORP | 18 | Q2 2018 | 14.6% |
VANGUARD TAX-MANAGED INTL FD | 15 | Q3 2023 | 100.0% |
BERKSHIRE HATHAWAY INC DEL | 14 | Q3 2019 | 13.8% |
ZIOPHARM ONCOLOGY INC | 13 | Q2 2018 | 0.6% |
CROWN CASTLE INTL CORP NEW | 12 | Q3 2017 | 43.9% |
MULTIPLAN CORPORATION | 12 | Q3 2023 | 0.3% |
MULTIPLAN CORPORATION | 8 | Q3 2022 | 26.3% |
TIME WARNER INC | 8 | Q3 2015 | 17.6% |
View Michael & Susan Dell Foundation's complete holdings history.
Latest filings
Type | Filed |
---|---|
144 | 2024-04-08 |
144 | 2024-03-21 |
13F-HR | 2024-02-14 |
144 | 2023-12-27 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
View Michael & Susan Dell Foundation's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.